NanoAssemblr™ Blaze nanoparticle formulation system

Supplied by Cytiva


  • NIB0061 | NANOASSEMBLR BLAZE+ SYSTEM UPGRADE
  • NIB0061 | NANOASSEMBLR BLAZE+ SYSTEM UPGRADE
Average lead time:
Call for Lead Time
Need Assistance?

Jump to Section
Product Description
NanoAssemblr™ Blaze+™ System Upgrade
Specifications
Inventory Number:
GEHNIB0061EA
Part Number:
NIB0061
Supplier:
Cytiva
Supplier's Lead Time:
Call for Lead Time
Quantity:
1 per EA
Contract Availability:
GSA
Country of Origin:
Canada
Features and Benefits 1::
Efficient: Validate end-to-end clinical manufacturing processes, including tangential flow filtration (TFF), sterile filtration, and fill/finish operations on a preclinical system with a simplified setup and shorter run times, saving time and resources.
Features and Benefits 2::
Flexible volume options: Select the Blaze system for low-volume applications (up to 1 L) or upgrade to the Blaze+ system for high-volume applications (up to 10 L), enabling toxicity, stability, and large-cohort in vivo animal studies.
Features and Benefits 3::
Closed system environment: The Blaze+ system provides a closed system environment that enables external vessel connections and includes a software upgrade, reducing the risk of contamination during scale-up.
Features and Benefits 4::
Scalable: Easily transfer critical process parameters (CPPs) to the NanoAssemblr™ commercial formulation system, enabling smooth technology transfer to a cGMP facility.
Features and Benefits 5::
Reproducible: NxGen™ technology ensures consistent, controlled mixing conditions, enabling reproducible, robust particle formation.
Overview:
The NanoAssemblr™ Blaze and Blaze+ systems streamline the process development of lipid nanoparticle (LNP) formulation, enabling the efficient scaling from early research through preclinical and early clinical development. With flexible volume options and a closed system environment, these systems support early chemistry, manufacturing, and control (CMC) studies and large-scale protocol development for upstream and downstream operations, providing valuable insights into processes and consumables required for GMP manufacturing.
Overview 2:
NxGen™ cartridges and tubing kits Single-use NxGen™ cartridges reduce the risk of cross-contamination and are available with or without in-line dilution, which automates a key process and streamlines the LNP workflow. The cartridges use the same mixer as the NanoAssemblr™ Ignite+ and NanoAssemblr™ commercial formulation system, enabling the direct transfer of CPPs from bench to process development and clinical and commercial production.
Overview 3:
The single-use tubing kit enables external vessel connections and a closed-system environment for the Blaze+ system.
Overview 4:
Starting June 2025, customers can purchase the new NxGen™ Blaze cartridges for the NanoAssemblr™ Blaze nanoparticle formulation system and will have the option to reuse them. Blaze system NxGen™ cartridges remain validated for single use only, up to 1 L on the Blaze system or 10 L on the Blaze+ system. Further information can be found in the Blaze user guide.
Additional Information

Contact the GSS Team Today!
GSS-Sales@govsci.com | 800.248.8030 | www.govsci.com

Government Scientific Source
ISO 9001:2015 Certified
Copyright 2026, Government Scientific Source. All Rights Reserved.